Semax vs Selank: Which Nootropic Peptide Is Better?

Semax and Selank are the two most widely used nootropic peptides. Both were developed in Russia and have been approved there as medications — Semax for stroke and cognitive impairment, Selank for anxiety disorders. Despite being grouped together as "brain peptides," they work through different mechanisms and are suited to different cognitive goals. Understanding these differences is key to choosing the right one.

Semax is a synthetic analog of ACTH (adrenocorticotropic hormone), specifically a modified fragment of the ACTH 4-10 sequence with a Pro-Gly-Pro tripeptide extension that increases stability. It does not have the hormonal effects of ACTH (it does not raise cortisol) — instead, it acts as a neuroprotective and neurotrophic agent.

Semax increases brain-derived neurotrophic factor (BDNF) expression, which promotes neuronal growth, survival, and synaptic plasticity. It also modulates serotonin and dopamine metabolism, enhances attention and working memory, and has documented neuroprotective effects against ischemic damage (stroke).

The cognitive effects are stimulating — Semax tends to increase mental energy, focus, and clarity. Users often describe it as a clean, subtle focus enhancer without the jitteriness of stimulant drugs.

Selank is a synthetic analog of tuftsin, an endogenous immunomodulatory peptide, with a Pro-Gly-Pro tail for stability. Its primary mechanism involves modulating GABA receptors — specifically enhancing GABA-A receptor sensitivity, producing anxiolytic (anti-anxiety) effects similar to benzodiazepines but without sedation or dependence.

Selank also influences serotonin and norepinephrine pathways and has immunomodulatory effects (it can modulate immune function through its tuftsin base). The cognitive effects lean toward calming — Selank reduces anxiety, stabilizes mood, and allows clearer thinking by reducing the mental noise of anxiety and stress.

Where Semax is stimulating, Selank is calming. This is the fundamental difference between the two.

Both peptides are administered intranasally, which allows them to bypass the blood-brain barrier more effectively and reach the central nervous system quickly.

Semax: 200-600 mcg intranasally, 1-3 times daily. A typical starting dose is 200 mcg in the morning. Effects are felt within 15-30 minutes and last 4-6 hours. Higher doses (600-900 mcg) are used in clinical settings for neurological conditions.

Selank: 200-400 mcg intranasally, 1-3 times daily. Can be taken morning and afternoon for sustained anxiolytic effect. Effects are typically felt within 15-30 minutes. The calming effect is subtle rather than sedating.

Both are commonly cycled 2-4 weeks on, 1-2 weeks off, though some users take them continuously at lower doses.

Yes, Semax and Selank are commonly used together. The combination provides stimulating focus (Semax) without anxiety or overstimulation (Selank). This is one of the most popular nootropic peptide stacks.

A typical combined protocol: Semax 200-400 mcg + Selank 200-400 mcg intranasally in the morning and optionally again in the early afternoon. The Selank smooths out any edginess from Semax, while Semax prevents the mild sedation some people experience from Selank alone.

Some nasal spray products combine both peptides in a single formulation for convenience.

Choose Semax if: Your primary goal is cognitive enhancement — better focus, sharper memory, more mental energy. You do not struggle with anxiety. You want something that feels mildly stimulating. Semax is the better choice for study sessions, demanding cognitive work, or overcoming brain fog.

Choose Selank if: Your primary issue is anxiety that interferes with clear thinking. You want calm focus rather than stimulated focus. You have trouble sleeping because of racing thoughts (Selank before bed can help). Selank is the better choice when anxiety is the bottleneck to cognitive performance.

Choose both if: You want the best of both worlds — enhanced cognition with a calm, anxiety-free mental state. The stack is well-tolerated and the mechanisms are complementary.

Both are research compounds in most countries outside Russia. While they have been approved as medications in Russia with a reasonable safety profile, Western clinical data is limited.